FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention proposes using the compound (R/S)-(-/+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman or (S)-(+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman or their salts for preparing a medicinal agent. This agent is used in treatment of extrapyramidal motor disorders, in particular, in treatment of unfavorable effects of anti-parkinsonic preparations and using (S)-(+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman in combination with an anti-parkinsonic preparation for preparing the combined medicinal agent. Also, invention relates to a pharmaceutical composition for treatment of extrapyramidal disorders and a set of the same designation. Proposed compounds are able to prevent catalepsy caused by usual anti-dopaminergic preparations and they are strong agonists of 5-HT1A-receptors in combination with antagonism to dopamine D2-receptors and interaction with D3-receptors that provides positive effects on extrapyramidal system in treatment of dyskinesia.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
26 cl, 10 ex
| Title |
Year |
Author |
Number |
| NOVEL USE OF SUBSTITUTED AMINOMETHYLCHROMANS |
2002 |
- Khenning Bettkher
- Ral'F Defant
- Gerd Bartoshik
- Germann Russ
- Frank Veber
- Kristof Zejfrid
|
RU2322443C2 |
| NEW USING (R)-(-)-2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS |
2001 |
- Bartoshik Gerd
- Russ German
- Zejfrid Kristof
- Veber Frank
|
RU2278663C2 |
| NOVEL USING SUBSTITUTED AMINOMETHYLCHROMANS IN TREATMENT OF MOTION DISORDER OR UNDESIRABLE EFFECT CAUSED BY AGENTS THAT ARE ADMINISTRATED IN TREATMENT OF EXTRAPYRAMID MOTION DISORDER |
2002 |
- Bartoshik Gerd
- Russ Germann
- Zejfrid Kristof
- Bettkher Khenning
- Bokel' Khajnts-Germann
- Shmid-Grossmann Ushi
|
RU2320336C2 |
| NEW APPLICATION OF COMBINED SELECTIVE ANTAGONISTS OF DOPAMINE D2 RECEPTOR AND AGONISTS OF 5-НТ RECEPTOR |
2001 |
|
RU2283648C2 |
| METHOD FOR PREPARING 2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]CHROMANE |
2002 |
- Bokel' Khajnts-Germann
- Nojnfel'D Shteffen
- Ganttsert Ludvig
- Knirime Ral'F
- Zimon Ehl'Ke
- Defant Ral'F
- Khel'M Udo
- Rojbol'D Khel'Mut
|
RU2288229C2 |
| USING HEPTAPEPTIDE FOR TREATING PARKINSON'S DISEASE AND METHOD OF TREATING SUCH DISEASE |
2011 |
- Illarioshkin Sergej Nikolaevich
- Verejutina Irina Aleksandrovna
- Zhuravleva Elena Jur'Evna
- Andreeva Ljudmila Aleksandrovna
- Mjasoedov Nikolaj Fedorovich
|
RU2450822C1 |
| CHROMON OXIME NEW DERIVATIVE AND ITS USE AS ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS |
2015 |
- Charvin, Delphine
- Manteau, Baptiste
- Pomel, Vincent
- Conquet, Francois
|
RU2672569C2 |
| 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZIOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(PROPYNYL)-7H-PYRAZOLO-[4, 3-e]-[1, 2, 4]-TRIAZOLO-[1, 5-c]PYRIMIDINE-5-AMINE |
2006 |
- Bojl Krejg D.
- Chakkalamannil Samjuehl'
- Shakh Unmesh G.
- Lakhovich Zhan Eh.
|
RU2417997C2 |
| COMPOUNDS, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, SELECTIVE ANTAGONISTS OF 5-HT -RECEPTOR |
2001 |
- Bettkher Khenning
- Bartoshik Gerd
- Kharting Jurgen
- Van-Amsterdam Kristof
- Zejfrid Kristof
|
RU2280034C2 |
| THERAPEUTIC AGENTS FOR USE IN PREVENTING AND/OR TREATING HYPERKINETIC MOTOR DISORDERS |
2014 |
- Gavalda Batala Nuriya
- Insa Boronat Raul
- Rejg Bolano Nuriya
|
RU2685502C2 |
